SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix's upcoming earnings are sparking active debate, especially after the stock traded down in the after-hours session. While revenue was in line with estimates, EPS missed, and some community members are attributing the dip to a tax dispute in Brazil and broader concerns about content. A potential stock split and the impact of increased competition and advertising revenue are also key talking points.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

NBIS is experiencing a significant pullback, leading to community discussions about potential bottom levels and whether it's a buying opportunity or a sign of deeper issues. Despite the recent downturn, some investors maintain a bullish outlook, citing the Microsoft deal and long-term growth potential in the AI sector, while others express concerns about overvaluation and potential further declines.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

WBD is trending due to speculation around a potential acquisition, with community members weighing the possibility of a deal with Paramount Skydance or other interested parties like Netflix and Comcast. Discussions involve potential offer prices, the company's debt, and the strategic value of WBD's content library. The community is actively debating the likelihood of a buyout versus the company proceeding with its planned separation.

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson’s disease. The company was founded by Rogerio Vivaldi Coelho and Goeffrey Robin Race on April 23, 2007 and is headquartered in Burlington, MA.

Minerva Neurosciences Inc

Minerva Neurosciences ($NERV) is trending after announcing a $200M financing deal, sparking a surge in price and high volatility. The community is debating the potential for a short squeeze versus dilution concerns, while some traders are shifting focus to other trending stocks like $BYND. Bullish investors are optimistic about the Phase 3 trial for their schizophrenia treatment.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

Intuitive Surgical is trending due to anticipation surrounding its upcoming earnings report, with the community actively discussing potential outcomes and guidance. Bullish sentiment suggests the company will beat expectations, driven by strong global adoption of its da Vinci systems and procedure growth, despite concerns about tariffs and margin pressures. Traders are also closely monitoring unusual options activity and technical indicators for potential short-term opportunities.

GSI Technology, Inc. engages in the design, development and marketing of memory products primarily for the networking, and telecommunications markets. Its product includes Static Random Access Memory, or SRAM, which incorporated in networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations and network access equipment. It also offers services to the ongoing needs of the military, industrial, test and measurement equipment, automotive and medical markets for SRAMs .The company was founded by Lee-Lean Shu and Robert Yau in March 1995 and is headquartered in Sunnyvale, CA.

GSI Technology Inc

GSIT is trending due to excitement around its Gemini APU, which a Cornell study showed matches GPU performance with significantly less energy consumption. The community is discussing potential partnerships, buyout scenarios, and the long-term implications for AI and data centers, while some are wary of a recent stock offering impacting the price. Overall, the focus is on GSIT's potential to disrupt the AI market with its energy-efficient technology.

Texas Instruments Incorporated engages in the design and manufacture of semiconductors. It operates through the following segments: Analog, Embedded Processing, and Other. The Analog segment semiconductors change real-world signals, such as sound, temperature, pressure or images, by conditioning them, amplifying them and often converting them to a stream of digital data that can be processed by other semiconductors, such as embedded processors. The Embedded Processing segment involves handling specific tasks and can be optimized for various combinations of performance, power, and cost, depending on the application. The company was founded in 1930 and is headquartered in Dallas, TX.

Texas Instruments Inc.

Texas Instruments is trending following its latest earnings report, with revenue exceeding expectations but EPS falling slightly short, leading to mixed sentiment. The community is actively discussing whether the results justify the stock's valuation amidst broader concerns about the macro environment and potential tariff impacts. Some believe TXN is undervalued and poised for a rally, while others are wary of the company's guidance and competitive landscape.

Sweetgreen, Inc. owns and operates a chain of salad restaurants. It offers drinks, sides, local bowls, salads, plates, and warm bowls. The company was founded by Nicolas Jammet, Jonathan Neman, and Nathaniel E. Ru in November 2006 and is headquartered in Los Angeles, CA.

Sweetgreen Inc - Ordinary Shares - Class A

Sweetgreen ($SG) is trending as investors discuss its potential as a robotics play, especially compared to its peers; the acquisition of SPYCE is getting attention. Some traders are weighing whether to accumulate shares long-term, citing the company's cheap valuation compared to competitors, while others point to upcoming earnings as a possible catalyst. Recent commentary from Wells Fargo adjusting its rating to Overweight has also entered the conversation.

rYojbaba Co., Ltd. engages in providing consulting and health services to improve and restore physical and mental health diminished by work-related stress. It operates through the Labor Consulting Services and Health Services segments. The Labor Consulting Services segment provides labor and corporate consulting services to foster constructive employment relationships between companies and employees. The Health Services segment provides health services through osteopathic clinics and osteopathic beauty salons to alleviate physical ailments primarily created by work related stress. The company was founded by Masataka Sakai on January 5, 2015 and is headquartered in Fukuoka, Japan.

rYojbaba Co. Ltd.

rYojbaba Co., Ltd. 

rYojbaba Co., Ltd. ($RYOJ) is trending due to a significant surge in price and volume, prompting discussions about potential short squeezes and comparisons to other recent high-momentum stocks. The community is actively speculating on targets and potential sympathy plays, with some noting the stock's low float and recent IPO status. News of partnerships may be contributing to market stimulation.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is trending due to a volatile reaction to earnings and a strategic pivot towards rare earth mineral production. Community members are debating the viability of the rare earth venture and the impact of a Wells Fargo downgrade, while also speculating about potential acquisitions. Overall, the discussion revolves around whether this rally is a sign of a true transformation or just another fleeting moment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Hillenbrand (HI) announced on Wednesday that it has entered into a definitive agreement to be acquired by an affiliate of Lone Star Funds in an all-cash transaction valuing the company at $3.8 billion.Shares of Hillenbrand jumped nearly 19% in premarket trading after the company said it would be bought for $32.00 per share, which represents a premium of approximately 37% over Hillenbrand's unaffected closing share price of $23.43 on August 12. The transaction is expected to close by the end of the first quarter of calendar year 2026.Retail sentiment on <a href="https://stocktwits.com/symbol/HI">Hillenbrand</a> improved to ‘neutral’ from ‘bearish’ territory compared to a day ago, with message volumes at ‘normal’ levels, according to data from Stocktwits.&nbsp;“The Board carefully reviewed a range of potential strategic alternatives, including interest from a number of parties, and determined that this transaction is in the best interest of Hillenbrand and its shareholders,” said Helen Cornell, Chairperson of the Board of Directors.Hillenbrand said that once the deal is closed, it will become a privately held company, and the company’s shares will no longer trade on the New York Stock Exchange. Shares of the company traded nearly 3% higher in Wednesday’s pre-market session.The company said during its fourth-quarter results that it would not be issuing financial guidance for fiscal year 2026.Hillenbrand is known for providing processing equipment and solutions to customers around the world through its Advanced Process Solutions and Molding Technology Solutions segments.&nbsp;Shares of Hillenbrand have declined nearly 14% this year and have fallen 6% in the last 12 months.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/why-is-dollar-tree-stock-rising-today/ch6nw5IR3NW">Why Is Dollar Tree Stock Rising Today?</a>

Hillenbrand To Go Private In Nearly $4B Deal With Affiliate Of Lone Star Funds

The company will be bought for $32.00 per share, which represents a premium of approximately 37% over Hillenbrand's unaffected closing share price on August 12.

Equity

AST SpaceMobile (ASTS) shares hit an all-time high of $98.59 on Tuesday, and the stock was the top trending ticker on Stocktwits, building on the momentum following its partnership with Verizon to support space-based cellular broadband across the United States.The retail user message count on <a href="https://stocktwits.com/symbol/ASTS">AST SpaceMobile</a> increased by over 200% over 24 hours on Stocktwits, as of Tuesday morning. Retail sentiment on the stock remained unchanged in the ‘extremely bullish’ territory compared to a day ago, with message volumes at ‘high’ levels, according to data from Stocktwits.A bullish user on Stocktwits believes that AST SpaceMobile stock will reach $150 next year.<stembedurl>https://stocktwits.com/V792/message/632280773</stembedurl>Last week, the company noted that the agreement with Verizon is to provide direct-to-cellular AST SpaceMobile service when needed for Verizon customers starting in 2026.AST SpaceMobile has deployed the most expansive commercial communications arrays in low Earth orbit, enabling direct connectivity to standard smartphones without requiring specialized hardware.The company’s network is designed to operate across premium low-band spectrum, the company's own licensed L-band and S-band spectrum, and up to 1,150 MHz of mobile network operator partners' low- and mid-band spectrum, globally. These capabilities advance AST SpaceMobile's efforts toward commercial service.&nbsp;“The agreement will extend the scope of Verizon’s 850 MHz premium low-band spectrum into areas of the U.S. that would benefit from the ubiquitous reach of space-based broadband technology,” said Abel Avellan, Founder and CEO of AST SpaceMobileAnother bullish user on Stocktwits expects the stock to hit $100 by the close of trading on Tuesday.<stembedurl>https://stocktwits.com/pathforward/message/632277086</stembedurl>Shares of AST SpaceMobile have jumped 357% this year and gained over 297% in the last 12 months.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/dominos-cfo-sees-early-q4-weakness-across-us-restaurant-industry/ch6mwQqR3ZT">Domino’s CFO Sees Early Q4 Weakness Across US Restaurant Industry</a>

In this photo illustration the AST SpaceMobile logo is seen on a smartphone and a pc screen. 

ASTS Stock Hit Fresh All-Time Highs Today: What’s Driving The Investor Buzz?

The retail user message count on AST SpaceMobile increased by over 200% over 24 hours on Stocktwits, as of Tuesday morning, while retail sentiment on the stock remained unchanged in the ‘extremely bullish’ territory.

Humana (HUM) has reportedly lost a lawsuit seeking to undo cuts to the bonus payments it receives from the federal Medicare insurance program.Bloomberg <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-10-14/humana-loses-second-lawsuit-to-reverse-medicare-bonus-cuts">reported</a> on Tuesday that a Texas judge ruled in favor of the federal government, affirming a downgrade of quality ratings that are tied to payments for Medicare Advantage. The judge had <a href="https://stocktwits.com/news-articles/markets/equity/humana-loses-lawsuit-over-medicare-bonus-cuts-stock-slides/ch8ks9QR5q8">dismissed</a> a similar case in July as well.Humana depends more than any other large insurer on revenue from the Medicare Advantage program, Bloomberg noted. About $3 billion was at stake in the lawsuit, the report said, citing consulting firm Capstone.Centers for Medicare &amp; Medicaid Services (CMS) assigns quality ratings, called stars, to Medicare Advantage plans, ranging from one to five, with five being the highest rating. Beneficiaries can use this data to help choose plans, and insurance companies can receive government bonus payments for higher ratings.Humana’s stock dropped as much as 4% at the time of writing. On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/HUM">HUM stock</a> stayed within the ‘bearish’ territory, coupled with ‘low’ message volume.<figure class="image"><img style="aspect-ratio:588/62;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_14_at_12_53_12_PM_png_e17a866cd8.webp" alt="HUM's Sentiment Meter and Message Volume as of 12:53 p.m. ET on Oct. 14, 2025 | Source: Stocktwits" width="588" height="62"><figcaption>HUM's Sentiment Meter and Message Volume as of 12:53 p.m. ET on Oct. 14, 2025 | Source: Stocktwits</figcaption></figure>Earlier this month, Humana <a href="https://stocktwits.com/news-articles/markets/equity/humana-stock-rises-after-insurer-reaffirms-full-year-earnings-guidance/chCrmVZR3fE">affirmed</a> its full-year earnings per share guidance provided in July.The insurer stated that it expects adjusted earnings per common share of $17 for the year ending Dec. 31, 2025, and diluted earnings per share of $13.77.The firm also stated that its preliminary 2026 Medicare Advantage (MA) Star Ratings align with the assumptions in its financial planning. As a result, there is no change to the incremental earnings potential for 2025 to 2028. The ratings data provided by the Centers for Medicare &amp; Medicaid Services was inadvertently accessible on CMS Plan Finder for a brief period on Oct. 1, 2025, the company stated.Humana has about 20% of its members currently enrolled in Medicare plans rated four stars and above for 2026, and 14% of members in 4.5-star plans for 2026, it said.“Based on all information available to date, the company remains confident in its 2026 Individual MA pricing and benefit design, including the expectation that it will double individual MA pre-tax margin in 2026 (excluding Stars), and believes it is positioned to return to membership growth in 2026,” the firm said.HUM stock rose 3% this year and fell about 2% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/novavax-major-shareholder-calls-for-sale-of-company-to-larger-pharma-entity/ch6moRsR3mh">Novavax Major Shareholder Calls For Sale Of Company To Larger Pharma Entity</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The MyHumana app page is displayed on a smartphone in the Apple App Store in front of the Humana Inc logo on October 30, 2024 in Chongqing, China. (Photo by Cheng Xin/Getty Images)

Humana Stock Slumps After Reportedly Losing Lawsuit Seeking To Undo Cuts To Medicare Bonus Payments

Bloomberg reported on Tuesday that a Texas judge ruled in favor of the federal government, affirming a downgrade of quality ratings that are tied to payments for Medicare Advantage.

Planet Labs (PL) is reportedly set to deploy a new constellation of Earth observation satellites, which are designed to deliver high-resolution, AI-enhanced imagery within an hour.According to a Bloomberg News <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-10-08/planet-labs-to-launch-satellites-promising-images-in-an-hour?srnd=homepage-americas">report</a>, the newly introduced monitors, known as Owl, will bolster Planet Labs’ current fleet of approximately 150 imagery spacecraft in orbit. The report added that these systems are designed to monitor changes, from natural disaster impacts to the movement of vessels and aircraft.Planet Labs is looking to build and launch nearly 40 Owl satellites in the coming few years, with the initial test launch for these slated towards late 2026, Chief Executive Officer Will Marshall told Bloomberg in an interview.“Looking at the nature of modern war situations from Israel in the Middle East to Ukraine, people have seen that satellites and drones are critical to information advantage, which in turn is critical to their security,” Marshall said, according to the report.Retail sentiment on <a href="https://stocktwits.com/symbol/PL">Planet Labs</a> remained unchanged in the ‘bullish’ territory compared to a day ago, with message volumes at ‘normal’ levels, according to data from Stocktwits. Shares of the company were up 1% in early trading.The report added that Nvidia Corp’s (NVDA) chips will be used in these Owl satellites and will help in using artificial intelligence to search and identify events on Earth quickly. Bloomberg noted that the company said this was to ensure that customers can make real-time decisions in case of disaster relief, intelligence gathering and military responses.Shares of Planet Labs have gained 638% in the last 12 months.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="http://stocktwits.com/news-articles/markets/equity/best-buy-shares-jump-2-as-jefferies-sees-advertising-boosting-margins/ch6EZaGR3in">Best Buy Shares Jump 2% As Jefferies Sees Advertising Boosting Margins</a>

In this photo illustration, a smartphone held in a hand shows the logo of Planet Labs PBC

Planet Labs To Provide Images Within An Hour Using New Earth Observation Satellites: Report

According to a Bloomberg News report, the newly introduced monitors, known as Owl, will bolster Planet Labs’ current fleet of approximately 150 imagery spacecraft in orbit.

Plug Power (PLUG) announced on Tuesday that it has appointed insider Jose Luis Crespo as its new Chief Executive Officer, succeeding long-time head Andy Marsh.&nbsp; Shares of the company fell over 1% at the opening bell.The company stated that Marsh will continue to serve as CEO during the transition period and has been appointed executive chair of the board, a position he will retain after March 2, 2026. In conjunction, George McNamee has been named Lead Director, and the company said that both Board appointments are effective Oct. 10, 2025.The appointment of Crespo is to be effective as of the date the company files its annual report for the year ended Dec. 31, 2025. This is expected in March 2026.&nbsp;“My focus will be on execution, profitability, and customer success, ensuring that Plug continues to convert its technology leadership into sustainable growth,” Crespo said.Retail sentiment on <a href="https://stocktwits.com/symbol/PLUG">Plug Power</a> improved to ‘extremely bullish’ from ‘bullish’ territory a day ago, with message volumes at ‘extremely high’ levels, according to data from Stocktwits.Crespo joined&nbsp;Plug Power in 2014 and most recently served as Chief Revenue Officer. The company stated that, in his roles with the firm for more than a decade, Crespo has played a pivotal role in Plug’s growth, serving as the primary architect of a sales funnel that has generated over $8 billion in transformational opportunities.&nbsp;Plug also said that Crespo has been instrumental in strengthening relationships with key customers such as Amazon, Walmart, and Home Depot, while driving hydrogen adoption programs.Plug Power stock has rallied 76% in the last 12 months.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/applovin-rises-5-premarket-after-citigroup-recommends-buying-the-stock/ch6PfUIR3hP">AppLovin Rises 5% Premarket After Citigroup Recommends Buying The Stock Amid SEC Investigation Concerns</a>

Plug Power Names Insider Jose Luis Crespo As New CEO

Plug Power said that current CEO Andy Marsh will continue to serve in his position during the transition period and has been appointed executive chair of the board, a position he will retain following March 2, 2026. 

UnitedHealth Group’s (UNH) shareholder Accountability Board has reportedly filed a proposal seeking an independent chairman of the board, separate from the CEO.Bloomberg <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-10-03/unitedhealth-shareholder-wants-chairman-and-ceo-roles-separated">reported</a> on Friday that the nonprofit advocacy group’s proposal, if approved by shareholders, would ask the board to amend the company’s bylaws to codify an independent board chair. Currently, Stephen Hemsley serves as both CEO and chair of the board.“We were very disturbed to see recently that at such a trying time for UnitedHealth, the company chose to go backward and combine the CEO and chair roles,” Accountability Board President Matt Prescott said, as reported by Bloomberg. Prescott also called for a stronger leadership structure at the insurer while declining to disclose the size of the group’s stake in UNH, the report said. However, he noted that the stake meets the minimum requirement to file a shareholder proposal.The report noted that it is unclear whether the Accountability Board’s resolution will proceed to a shareholder vote.Shares of UNH traded 3% higher at the time of writing. On Stocktwits, retail sentiment regarding <a href="https://stocktwits.com/symbol/UNH">UNH stock</a> remained within the ‘bearish’ territory, while message volume remained at ‘low’ levels.Hemsley has been chairman of the company’s Board of Directors since 2017. Before that, he also served as CEO. He was reappointed as CEO in May when Witty <a href="https://stocktwits.com/news-articles/markets/equity/unitedhealth-suspends-2025-guidance-ceo-andrew-witty-resigns/chi8S4qRbZQ">stepped down</a>, citing personal reasons, but while retaining his chair position. This is contradictory to UnitedHealth’s principle of governance, which also calls for separate roles, Bloomberg noted.The insurer issued <a href="https://stocktwits.com/news-articles/markets/equity/united-health-price-target-lowered-by-bernstein-after-soft-guidance-but-retail-hopes-for-long-term-recovery/chrXElQRdRK">fresh guidance</a> of full-year revenue of $445.5 billion to $448.0 billion and adjusted earnings of at least $16.00 per share in July after suspending its previous outlook in May, citing higher medical costs. The company had previously forecast adjusted profit of $29.50 to $30.00 per share, nearly double its latest forecast. The company also <a href="https://stocktwits.com/news-articles/markets/equity/united-health-s-cfo-shake-up-doesn-t-deter-retail-bulls-traders-call-stock-a-2018-level-opportunity/chr3k1VRdGi">appointed</a> Wayne S. DeVeydt as CFO in July, replacing John F.Rex.UNH stock is down 28% this year and approximately 39% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tesla-gets-price-target-hike-from-jpmorgan-after-q3-deliveries-beat-estimates/chCumk4R3QJ">Tesla Gets A Price Target Hike From JPMorgan After Q3 Deliveries Beat Estimates</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a smartphone displays the logo of UnitedHealth Group Incorporated. (Photo illustration by Cheng Xin/Getty Images)

UnitedHealth Shareholder Proposes Distinct Chairman And Chief Executive Roles: Report

Stephen Hemsley currently serves as both CEO and Chairman of the Board.

Anavex Life Sciences (AVXL) on Thursday said that its investigational drug achieved its primary endpoint in a mid-stage trial and demonstrated safety and tolerability in adults with Schizophrenia.Shares of the company soared 9% in Thursday’s pre-market session.The company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/10/02/3160275/29248/en/Anavex-Life-Sciences-Announces-Positive-Topline-Results-from-Phase-2-Study-of-ANAVEX-3-71-for-the-Treatment-of-Schizophrenia.html">said</a> that the safety profile of ANAVEX3-71 was consistent with previous studies in healthy volunteers, and no serious treatment-emergent adverse events were reported in the study.The company is evaluating the drug in the treatment of Schizophrenia, a persistent and often disabling mental illness impacting how a person thinks, feels, and behaves, and affects nearly 24 million people worldwide. According to Anavex, the illness impacts 2.8 million people in the U.S. alone.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/AVXL">AVXL stock</a> jumped from ‘neutral’ to ‘bullish’ over the past 24 hours, while message volume stayed at ‘high’ levels.Anavex also said on Thursday that encouraging trends were observed in biomarkers of Schizophrenia in the study that support continued development. This includes a reduced glial fibrillary acidic protein in patients receiving ANAVEX3-71 compared to placebo.GFAP is a marker of neuroinflammation, and a reduction in it suggests a potential disease-modifying effect that may become more pronounced with longer treatment durations, the company said.The company on Thursday also <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/10/02/3160281/29248/en/Anavex-Life-Sciences-Announces-Successful-Development-of-Once-Daily-Oral-Tablet-Formulation-for-the-ANAVEX-3-71-Program.html">announced</a> the successful development of a once-daily oral tablet formulation for the ANAVEX3-71 program. The tablet exhibits superior pharmacokinetics compared to the current immediate-release oral capsule, enabling once-daily dosing, it added.AVXL stock is down 16% this year but up approximately 59% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/rivian-slashes-full-year-delivery-guidance-after-drop-in-q3-figures/chCrfpbR3OH">Rivian Slashes Full-Year Delivery Guidance After Drop In Q3 Figures</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Anavex Life Sciences Stock Just Shot Up 7% Today – Here’s An Important Update

The company said that its investigational drug for Schizophrenia achieved its primary endpoint in a mid-stage trial.

Amgen (AMGN) on Friday announced a $650 million expansion of its U.S. manufacturing network, on the heels of President Trump’s latest pharmaceutical tariff announcement.Trump said in a post on Truth Social on Thursday that the United States will impose a 100% tariff on branded and patented pharmaceutical products starting October 1 unless manufacturers are actively building plants in the country.Amgen <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.amgen.com/newsroom/press-releases/2025/09/amgen-announces-650m-expansion-of-us-manufacturing-creating-hundreds-of-new-jobs">said</a> on Friday that the planned investment will support increased drug production at the company's biologics manufacturing facility in Juncos, Puerto Rico. The investment is also expected to create about 750 jobs, including construction roles and skilled manufacturing jobs. According to Amgen, the company has invested more than $40 billion in U.S. manufacturing and research and development since late 2017.Earlier this year, the company announced a $900 million expansion of its Ohio manufacturing facility, which followed a late-2024 announcement of a $1 billion expansion to establish a second drug substance manufacturing facility in North Carolina.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/AMGN">AMGN stock</a> fell from ‘bullish’ to ‘neutral’ territory over the past 24 hours, while message volume stayed at ‘high’ levels.<figure class="image"><img style="aspect-ratio:622/62;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_26_at_1_54_57_PM_png_99b99c433b.webp" alt="AMGN's Sentiment Meter and Message Volume as of 1:55 p.m. ET on Sept. 26, 2025 | Source: Stocktwits" width="622" height="62"><figcaption>AMGN's Sentiment Meter and Message Volume as of 1:55 p.m. ET on Sept. 26, 2025 | Source: Stocktwits</figcaption></figure>Jefferies analyst Akash Tewari stated on Friday that Trump’s tariffs may not have a material impact on pharmaceutical companies, as several large-cap pharmaceutical firms have already announced plans to establish U.S. manufacturing facilities.A Stocktwits user echoed the analyst’s sentiment, stating that Amgen will also likely be unaffected by the tariffs.<stembedurl>https://stocktwits.com/BobBijawklah/message/630132763</stembedurl>AMGN stock is up 4% this year and down by about 15% over the past 12 months.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/bioaffinity-technologies-stock-surge-over-cypath-lung-case-studies/chDVjeMR3ea">bioAffinity Technologies Stock Surged A Whopping 79% Today – Here’s An Important Update</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The company logo and the lettering of the biotechnology company Amgen can be seen on the facade of the company's headquarters in Munich (Bavaria) on January 14, 2025. Photo: Matthias Balk/dpa (Photo by Matthias Balk/picture alliance via Getty Images)

Amgen Announces $650M Expansion Of US Manufacturing Network After Trump’s Pharma Tariff Announcement

Amgen said that the planned investment will support increased drug production at the company's biologics manufacturing facility in Juncos, Puerto Rico.

Uber Technologies (UBER) reportedly expects faster-than-expected growth for its grocery and retail delivery segment. &nbsp;Bloomberg <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-09-26/uber-sees-non-takeout-deliveries-becoming-12-5-billion-business?srnd=homepage-americas">reported</a> on Friday, citing a company spokesperson, that Uber expects non-restaurant deliveries to hit an annual run rate of $12.5 billion in gross bookings by the end of 2025. This marks a growth of over 25% from the $10 billion run rate the company shared earlier this year in May, the report added. &nbsp;<a href="https://stocktwits.com/symbol/UBER">UBER shares</a> traded flat at the time of writing. On Stocktwits, retail sentiment regarding UBER stock shifted from ‘neutral’ to ‘bearish’ territory over the past 24 hours.In the second quarter, Uber’s delivery segment saw a 20% increase in gross bookings to $21.7 billion, while revenue jumped 25% to $4.1 billion. In fact, in the second quarter, the delivery segment accounted for nearly half of the company’s gross bookings.However, CEO Dara Khosrowshahi said in August that Uber still has “a long runway to drive further adoption” in delivery, noting that 75% of its rideshare customers have not tried ordering grocery and retail goods from the Uber app, as reported by Bloomberg.Rebecca Payne, group product manager for grocery and retail, told Bloomberg that 6 p.m. on Sundays is the peak time for grocery orders on Uber, and the most popular items are bananas, limes, lemons, cucumbers, Hass avocados, and red Roma tomatoes. More updates about the business are expected at the annual Groceryshop conference in Las Vegas on Sunday, the report added.In the past few months, Uber has announced partnerships or collaborations with multiple names in the grocery and retail sectors, including grocer ALDI, electronics company Best Buy, beauty retailer Sephora, and even Dollar Tree.Earlier this week, the company also announced weekly offers on groceries through the Fresh Days program, which is available to customers in the U.S., Canada, the U.K., South Africa, France, Japan, Taiwan, and Spain. For Fresh Days in the U.S., Uber One members will get 30% off every Tuesday on select fresh produce, meats, dairy, and eggs.Uber stock is up 62% this year and approximately 27% over the past 12 months.&nbsp;Get updates to this developing story <a href="https://stocktwits.com/news-articles/markets/equity/uber-reportedly-expects-non-restaurant-deliveries-to-surge-faster-than-previously-expected/chDVlUmR3eW">directly on Stocktwits.</a>

An Uber Eats courier rides a bicycle through the streets of Amsterdam, Netherlands, on September 10, 2025. The rider carries a large green delivery bag. (Photo by Michael Nguyen/NurPhoto via Getty Images)

Uber Reportedly Expects Non-Restaurant Deliveries To Surge Faster Than Previously Expected

Bloomberg reported on Friday, citing a company spokesperson, that Uber expects grocery and retail deliveries to hit an annual run rate of $12.5 billion in gross bookings by the end of 2025.

Activist hedge fund Engine Capital is reportedly pushing Acadia Healthcare (ACHC) to refresh its board as it faces multiple federal investigations.According to a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.ft.com/content/e96d221b-c275-4b3e-86aa-250f784d55dc">report</a> by The Financial Times, the fund holds a roughly 3% stake in Acadia and has written a letter to the company's board, requesting a review of its asset portfolio, improvements to its board of directors, and the halting of capital-intensive projects for new facilities.Acadia provides for-profit behavioral healthcare services. It is currently facing probes from the Department of Justice and Securities and Exchange Commission over allegations of holding patients against their will and falsifying insurance claims, the report noted.Shares of the company rose over 8% on Wednesday morning following the news. On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/ACHC">ACHC</a> stayed within the ‘bullish’ territory over the past 24 hours, while message volume stayed at ‘normal’ levels.Tennessee-headquartered Acadia operated a network of 274 behavioral healthcare facilities, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics, with approximately 12,100 beds in 39 states and Puerto Rico as of the end of June. The company estimates that it serves more than 82,000 patients daily.As per FT, Engine Capital accused Acadia of maintaining a “growth at any cost” approach in its letter. It alleged that the approach has given rise to a bloated corporate structure and noted that a 2022 reorganisation left the company with an unwieldy management structure that has stifled the company’s turnaround.The firm also urged the company to add new directors with experience in behavioral health and capital allocation, while noting that the current board has no director with relevant operating experience. The hedge fund also encouraged the company to consider selling its assets and repurchasing shares.ACHC stock is down 40% this year and approximately 69% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/uniqure-stock-rises-pre-market-after-investigational-huntingtons-disease-drug-slows-disease-in-trial/chD1GAOR33X">uniQure Stock Rises Pre-Market After Investigational Huntington’s Disease Drug Slows Disease In Trial</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration an Acadia Healthcare logo is seen on a smartphone and a pc screen. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images)

Acadia Healthcare Stock Surges After Activist Hedge Fund Reportedly Seeks Board Revamp

According to a report by The Financial Times, the fund has written a letter to the company's board, requesting a review of its asset portfolio and improvements to its board.

According to a report by The Financial Times, the fund holds a roughly 3% stake in Acadia and has written a letter to the company's board, requesting a review of its asset portfolio, improvements to its board, and the halting of capital-intensive projects for new facilities.

iShares Trust - iShares ESG Aware 60/40 Balanced Allocation ETF

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

) beat quarterly earnings? 
 
*Powered by Polymarket

EAOR
iShares ESG Aware 60/40 Balanced Allocation ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest EAOR News

EAORiShares ESG Aware 60/40 Balanced Allocation ETF